ClinicalTrials.gg
RecruitingNCT06708169Updated Nov 19, 2026

Effect of Preemptive Education on the Incidence of Maternal Intraoperative Shivering in Elective Cesarean Delivery

An interventional study of preemptive education provided by anesthesiologists in Shivering and Spinal Anesthesia, sponsored by Seoul National University Hospital. Recruiting at 1 site in South Korea. Open to female participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Dec 2024; still recruiting 1 year 11 months later.
Updated Nov 19, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
19 Years and older
Sex
Female
01

Study summary

The goal of this study is to learn about the effect of preemptive education on reducing intraoperative maternal shivering in elective cesarean delivery. The main question it aims to answer is:

Does preemptive education by anesthesiologists reduce intraoperative maternal shivering in elective cesarean delivery?

02

Conditions studied

  • Shivering
  • Spinal Anesthesia
03

In context

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,903 studies on the registry; 276 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 19 years or older
  • Gestational age 37 weeks or above
  • Elective surgey

Exclusion criteria

Exclusion Criteria:

  • Emergency surgery
  • Any sign of onset of labor
  • Difficulty with communication
  • of spinal anesthesia
  • Pre-eclampsia
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
130 participants (estimated)

Study arms

  • No intervention
    Patients without preoperative education by anesthesiologists

    Patients get minimal information about the surgical process and their questions will be answered by obstetrician.

  • Experimental
    Patients with preoperative education by anesthesiologists

    Patients get preemptive education about the whole process from anesthesia to recovery stage within 15 minute by anesthesiologists.

    Behavioral: preemptive education provided by anesthesiologists

Interventions

  • Behavioralpreemptive education provided by anesthesiologists

    A preemptive education about 4 stages (prepare, anethesia, surgery, and recovery) by anesthesiologists within 15 minute.

06

What researchers measure

Primary outcomes

  1. Number of participants with intraoperative maternal shivering

    Record when shivering occurred within the time frame

    Time frame: From the moment the patient enters the operating room (0 minute) until leaving the operating room on the same day, expected to be up to 180 minutes.

Secondary outcomes

  1. Intraoperative body temperature

    Time frame: 0, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180 minutes after entering the operating room until the end of surgery.

  2. Intraoperative pain (Numeric rating scale, NRS).

    NRS 0: no pain 1-3: mild pain (nagging, annoying, interfering little with acitivities of daily living (ADLs)) 4-6: moderate Pain (interferes significantly with ADLs) 7-10: severe Pain (disabling; unable to perform ADLs) Record when the patient complained pain within the time frame

    Time frame: From the moment the patient enters the operating room (0 minute) until leaving the operating room on the same day, expected to be up to 180 minutes.

  3. Spinal anesthesia level (dermatome)

    Time frame: From the intrathecal injection (0 minute) until at the end of surgery (0, 5, 10, 25, 40, 55, 75 minute, at the end of surgery)

  4. Post-operative spinal anesthesia level in recovery room

    The level(dermatome) of spinal anesthesia will be checked by pin-prick test by an anesthesiologist or nurse.

    Time frame: From the time the patient enters the recovery room (0 minute) until leaving the recovery room (0, 15, 30, 45 minute, at the time the patient leaves the recovery room)

  5. Number of Participants with Post-operative shivering in recovery room

    Time frame: From the time the patient enters the recovery room (0 minute) until leaving the recovery room (0, 15, 30, 45 minute, at the time the patient leaves the recovery room)

  6. Post-operative body temperature in recovery room

    Time frame: From the time the patient enters the recovery room (0 minute) until leaving the recovery room (0, 15, 30, 45 minute, at the time the patient leaves the recovery room)

  7. Post-operative nausea and vomiting in recovery room (by questionnaire)

    Nausea and vomiting will be assessed by questionnaire. (yes/no)

    Time frame: From the time the patient enters the recovery room (0 minute) until leaving the recovery room (0, 15, 30, 45 minute, at the time the patient leaves the recovery room)

  8. Patient's satisfaction by questionnaire

    Patient's satisfaction about pre-operative preparation, anesthesia, and surgery by questionnaire. Participants will respond their satisfaction by score 0-10. (A higher score means higher satisfaction. )

    Time frame: From the end of surgery until 24 hours after surgery

  9. Pain (assessed by NRS) until post-operative day 1

    NRS (numeric rating scale) is detailed at Outcome number 3.

    Time frame: At 6, 12, 18, 24 hours after the end of surgery

  10. Analgesic dosage (Morphile miligram equivalents) until post-operative day 1

    Time frame: From the end of surgery until 24 hours after surgery

  11. Obstetric quality of recovery until post-operative day 1

    Quality of recovery will be assessed by Obstetric Quality of Recovery-11K survery, which is a questionnaire completed by participants. Higher score means higher quality of recovery.

    Time frame: At 24 hours after surgery

07

Study locations

1 of 1 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Dec 2024 (actual). Primary completion is estimated for Feb 2028, 38 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 19, 2026: primary completion Feb 2026 → Feb 2028 and completion Aug 2026 → Aug 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 31, 2024
First posted
Nov 27, 2024
StartActual
Dec 9, 2024
Primary completionEst.
Feb 28, 2028was Feb 2026
CompletionEst.
Aug 31, 2028was Aug 2026
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Feb 28, 2026→Feb 28, 2028
Nov 19, 2026
Study completion
Aug 31, 2026→Aug 31, 2028
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Primary completion Feb 28, 2026→Feb 28, 2028
    Study completion Aug 31, 2026→Aug 31, 2028
    + 3 other changes: verification date, oversight details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06708169
Responsible party
Sponsor
First posted
Nov 27, 2024
Start date
Dec 9, 2024
Primary completion
Feb 28, 2028 (estimated)
Completion
Aug 31, 2028 (estimated)
Last update
Nov 19, 2026

Study contacts

Jang
Contact
wwdzhl55@naver.com
821025640576

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion